Related references
Note: Only part of the references are listed.Curation of an international drug proprietary names dataset
Mohammad A. Khaleel et al.
DATA IN BRIEF (2022)
Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug-Drug Interactions: An Analysis From the French Pharmacovigilance Database
Louis Letinier et al.
FRONTIERS IN PHARMACOLOGY (2021)
Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future
Muaed Alomar et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2020)
Database of adverse events associated with drugs and drug combinations
Aleksandar Poleksic et al.
SCIENTIFIC REPORTS (2019)
Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database
Hanna K. Welch et al.
PHARMACOTHERAPY (2018)
A curated and standardized adverse drug event resource to accelerate drug safety research
Juan M. Banda et al.
SCIENTIFIC DATA (2016)
Data Mining of the US FDA's Adverse Events Reporting System Database to Evaluate Drug-Drug Interactions Associated with Statin-Induced Rhabdomyolysis
Monica A. Munoz et al.
PHARMACEUTICAL MEDICINE (2016)
The Weber Effect and the United States Food and Drug Administration's Adverse Event Reporting System (FAERS): Analysis of Sixty-Two Drugs Approved from 2006 to 2010
Keith B. Hoffman et al.
DRUG SAFETY (2014)
Data Mining of the Public Version of the FDA Adverse Event Reporting System
Toshiyuki Sakaeda et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2013)
Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery
G. Niklas Noren et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2013)
Normalized names for clinical drugs: RxNorm at 6 years
Stuart J. Nelson et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2011)
Informatic tools and approaches in postmarketing pharmacovigilance used by FDA
Joyce Weaver et al.
AAPS JOURNAL (2008)
Duplicate detection in adverse drug reaction surveillance
G. Niklas Noren et al.
DATA MINING AND KNOWLEDGE DISCOVERY (2007)
'Extreme duplication' in the USFDA adverse events reporting system database
Lester Reich
DRUG SAFETY (2007)
Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events
G. Niklas Noren et al.
STATISTICS IN MEDICINE (2006)
Making the most of spontaneous adverse drug reaction reporting
PC Waller
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2006)
A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions
EP van Puijenbroek et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2002)
Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports
SJW Evans et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2001)
The role of databases in drug postmarketing surveillance
EM Rodriguez et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2001)
Share Paper
